PUREfi Wealth’s Checkpoint Therapeutics CKPT Stock Holding History

PUREfi Wealth’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$40.4K	–	157
2025 Q1	$40.4K	Hold	10,000	–	–	0.04%	137
2024 Q4	$32K	Buy	+10,000	New	+$33.9K	0.03%	152

PUREfi Wealth's CKPT Position: Q2 2025 in Review

PUREfi Wealth sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 10,000 shares — an estimated $40.4K sold.

PUREfi Wealth first reported a position in CKPT in Q4 2024 and held it in 2 quarters. The position peaked at $40.4K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

PUREfi Wealth reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
PUREfi Wealth sold 10,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $40.4K.
PUREfi Wealth first reported a position in Checkpoint Therapeutics in Q4 2024 and held it in 2 quarters.
PUREfi Wealth's Checkpoint Therapeutics position peaked at $40.4K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on PUREfi Wealth's 13F filing for Q2 2025, filed 22 Jul 2025.